ARK WISE Expands Regenerative Medicine Facilities with New Cell Processing Center

ARK WISE, a company based in Shibuya, Tokyo, has recently obtained approval for the establishment of a new Cell Processing Center (CPC). This facility will enhance their regenerative medicine capabilities, aligning with the company's ongoing commitment to safety and quality in medical services. Officially, the new CPC, designated as FA3250001, received its certification from the Kanto-Shinetsu Bureau of Health, Labor and Welfare on September 4, 2025.

The CPC will serve under the auspices of North Aoyama D.CLINIC, where Dr. Yoshihisa Abo, the clinic's director, serves as the leading medical professional. This move is set against a backdrop of increasing societal expectations for safety and transparency in the field of regenerative medicine. The introduction of a second CPC at North Aoyama D.CLINIC (which already operates one CPC, FC3210045) is a noteworthy development, allowing for a more robust and diversified treatment structure.

Objectives of the New Facility

The new CPC is designed to streamline a variety of procedures that are critical in regenerative medicine, such as cell collection, cultivation, management, and administration. It aims to address age-related health issues like physical degeneration, heart failure, arterial sclerosis, chronic pain, and cognitive dysfunction across a diverse patient demographic. This dual-CPC setup is among a rare few in Japan, facilitating a more flexible and stable delivery of regenerative therapies.

The facility is equipped with advanced technology, including four large safety cabinets and ten CO₂ incubators. These tools provide an optimal environment for cell cultivation, assuring high-quality results through precise monitoring and control.

Enhancements in Healthcare Delivery

North Aoyama D.CLINIC is set to demonstrate unprecedented levels of operational efficiency through this dual-CPC arrangement. The clinic's infrastructure will allow for:

- Expanded treatment availability for a broader range of patients
- Reduced waiting times for procedures
- A reinforced ability to respond to unforeseen circumstances, such as equipment failures or disasters.

Safety Protocols and Treatment Efficacy

With the safety and quality of regenerative medicine as its top priority, North Aoyama D.CLINIC has implemented numerous measures to uphold high standards. This includes establishing a specialized committee composed of multi-disciplinary experts, rigorously reviewing treatment plans. As of now, the clinic has submitted twenty-three treatment plans across fifteen categories to the Ministry of Health, Labour and Welfare, ranging from age-related issues to chronic pain management.

To maintain stem cell quality, the CPC within the facility ensures that every aspect of the treatment process, from separation to infusion, is executed with utmost precision and care. The center boasts cleanroom environments compliant with ISO Class 5 standards, continuous monitoring of environmental conditions, and a state-of-the-art emergency alert system to enhance patient safety.

Diverse Administration Routes

Depending on patient needs, the clinic can offer a variety of administration techniques. Each method—be it local, intravenous, arterial catheterization, or intrathecal—involves carefully managed protocols to minimize complications, including vigilant monitoring of oxygen saturation and appropriate anticoagulation therapy when necessary.

Patients are reassured of the clinic's commitment to safety through transparency in reporting treatment outcomes. From March 2019 to August 2025, a total of 2,003 treatments were performed, yielding minimal transient complications such as localized pain and a very low incidence of severe adverse events.

The Vision of ARK WISE

Dr. Abo has emphasized that the establishment of the new CPC is integral to making regenerative therapies safer and more accessible for a greater number of patients. He stressed that, as demonstrated by their track record, safely delivering effective treatments is indeed possible when proper protocols are followed. He reiterated ARK WISE's commitment to societal responsibility, safety, and a personalized approach to patient care.

For those interested in learning more about the new CPC or to watch an explanatory video from Dr. Abo, additional resources and media are readily available through official channels.

About ARK WISE

Founded in March 2002, ARK WISE is committed to supporting healthcare innovation, aiming to stabilize and grow its associated medical institutions like North Aoyama D.CLINIC. The company also focuses on developing medical-related products and services. For more information, visit their corporate website at arkwise.jp.

Contact the PR team for inquiries regarding media coverage or interviews regarding the new CPC, treatment results, or Dr. Abo's expertise.